07:00 , May 6, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute promyelocytic leukemia (APL) Lysine-specific histone demethylase 1 (KDM1A; LSD1); KDM1B (LSD2) In vitro studies suggest that tranylcypromine-derived LSD1 and LSD2 inhibitors could help treat...